Skip to main content
. Author manuscript; available in PMC: 2013 Jul 24.
Published in final edited form as: J Immunother. 2012 Feb-Mar;35(2):179–188. doi: 10.1097/CJI.0b013e318247a5e9

Fig. 3.

Fig. 3

N-NK cAMP was compared to (a) T-NK 410.4 and (b) T-NK 66.1. Cells were stimulated in the presence of PGE2 for 30 minutes. Intracellular cAMP was assessed from cell lysates. Data represented as mean ± standard error fmol cAMP/1×105 cells in triplicate wells. Relative to N-NK, T-NK with PGE2 treatment *p<0.05.